A Prospective, Multicenter Study to Investigate the Pharmacokinetics, Safety, and Efficacy of Cadazolid Versus Vancomycin in Pediatric Subjects With Clostridium Difficile-associated Diarrhea
Phase of Trial: Phase II/III
Latest Information Update: 07 Aug 2018
At a glance
- Drugs Cadazolid (Primary) ; Vancomycin
- Indications Clostridium difficile infections; Diarrhoea
- Focus Pharmacokinetics; Therapeutic Use
- Sponsors Actelion Pharmaceuticals
- 30 May 2018 This trial has been completed in Hungary (end date: 2018-04-17).
- 23 May 2018 Status changed from suspended to discontinued.
- 22 Nov 2017 Status changed from recruiting to suspended.